1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Investment Feasibility Matrix
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Device Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Device Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Device Type, 2022-2032
5.3.1. Reprocessed Devices
5.3.1.1. Hospital
5.3.1.2. Others
5.3.1.3. SNP Analysis
5.3.1.4. Mutational Analysis
5.3.1.5. Microarray Analysis
5.3.1.6. RNA Interference
5.3.2. Other Device Types
5.4. Y-o-Y Growth Trend Analysis By Device Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Device Type, 2022-2032
6. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Service
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Service, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Service, 2022-2032
6.3.1. Extractable and Leachable
6.3.2. Material Characterization
6.3.3. Physical Testing
6.3.4. Bioburden Testing
6.3.5. Sterility Testing
6.3.6. Other Services
6.4. Y-o-Y Growth Trend Analysis By Service, 2017-2021
6.5. Absolute $ Opportunity Analysis By Service, 2022-2032
7. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Therapeutic Areas
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By Therapeutic Areas, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Therapeutic Areas, 2022-2032
7.3.1. Cardiology
7.3.2. Diagnostic Imaging
7.3.3. Orthopedic
7.3.4. IVD
7.3.5. Ophthalmic
7.3.6. General & Plastic Surgery
7.3.7. Drug Delivery
7.3.8. Endoscopy
7.3.9. Dental
7.3.10. Diabetes Care
7.3.11. Other Therapeutic Areass
7.4. Y-o-Y Growth Trend Analysis By Therapeutic Areas, 2017-2021
7.5. Absolute $ Opportunity Analysis By Therapeutic Areas, 2022-2032
8. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By End-use
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Mn) Analysis By End-use, 2017-2021
8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-use, 2022-2032
8.3.1. Hospital
8.3.2. Other End-uses
8.4. Y-o-Y Growth Trend Analysis By End-use, 2017-2021
8.5. Absolute $ Opportunity Analysis By End-use, 2022-2032
9. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia Pacific
9.3.5. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. U.S.
10.2.1.2. Canada
10.2.2. By Device Type
10.2.3. By Service
10.2.4. By Therapeutic Areas
10.2.5. By End-use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Device Type
10.3.3. By Service
10.3.4. By Therapeutic Areas
10.3.5. By End-use
10.4. Key Takeaways
11. Latin America Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Device Type
11.2.3. By Service
11.2.4. By Therapeutic Areas
11.2.5. By End-use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Device Type
11.3.3. By Service
11.3.4. By Therapeutic Areas
11.3.5. By End-use
11.4. Key Takeaways
12. Europe Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. U.K.
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Russia
12.2.1.7. Rest of Europe
12.2.2. By Device Type
12.2.3. By Service
12.2.4. By Therapeutic Areas
12.2.5. By End-use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Device Type
12.3.3. By Service
12.3.4. By Therapeutic Areas
12.3.5. By End-use
12.4. Key Takeaways
13. Asia Pacific Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. India
13.2.1.4. South Korea
13.2.1.5. Australia
13.2.1.6. Rest of APAC
13.2.2. By Device Type
13.2.3. By Service
13.2.4. By Therapeutic Areas
13.2.5. By End-use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Device Type
13.3.3. By Service
13.3.4. By Therapeutic Areas
13.3.5. By End-use
13.4. Key Takeaways
14. Middle East and Africa Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. South Africa
14.2.1.2. Saudi Arabia
14.2.1.3. UAE
14.2.1.4. Israel
14.2.1.5. Rest of MEA
14.2.2. By Device Type
14.2.3. By Service
14.2.4. By Therapeutic Areas
14.2.5. By End-use
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Device Type
14.3.3. By Service
14.3.4. By Therapeutic Areas
14.3.5. By End-use
14.4. Key Takeaways
15. Key Countries Medical Device Analytical Testing Outsourcing Market Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Device Type
15.1.2.2. By Service
15.1.2.3. By Therapeutic Areas
15.1.2.4. By End-use
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Device Type
15.2.2.2. By Service
15.2.2.3. By Therapeutic Areas
15.2.2.4. By End-use
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Device Type
15.3.2.2. By Service
15.3.2.3. By Therapeutic Areas
15.3.2.4. By End-use
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Device Type
15.4.2.2. By Service
15.4.2.3. By Therapeutic Areas
15.4.2.4. By End-use
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Device Type
15.5.2.2. By Service
15.5.2.3. By Therapeutic Areas
15.5.2.4. By End-use
15.6. U.K.
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Device Type
15.6.2.2. By Service
15.6.2.3. By Therapeutic Areas
15.6.2.4. By End-use
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Device Type
15.7.2.2. By Service
15.7.2.3. By Therapeutic Areas
15.7.2.4. By End-use
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Device Type
15.8.2.2. By Service
15.8.2.3. By Therapeutic Areas
15.8.2.4. By End-use
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Device Type
15.9.2.2. By Service
15.9.2.3. By Therapeutic Areas
15.9.2.4. By End-use
15.10. Russia
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Device Type
15.10.2.2. By Service
15.10.2.3. By Therapeutic Areas
15.10.2.4. By End-use
15.11. China
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Device Type
15.11.2.2. By Service
15.11.2.3. By Therapeutic Areas
15.11.2.4. By End-use
15.12. Japan
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Device Type
15.12.2.2. By Service
15.12.2.3. By Therapeutic Areas
15.12.2.4. By End-use
15.13. India
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Device Type
15.13.2.2. By Service
15.13.2.3. By Therapeutic Areas
15.13.2.4. By End-use
15.14. South Korea
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Device Type
15.14.2.2. By Service
15.14.2.3. By Therapeutic Areas
15.14.2.4. By End-use
15.15. Australia
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Device Type
15.15.2.2. By Service
15.15.2.3. By Therapeutic Areas
15.15.2.4. By End-use
15.16. South Africa
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Device Type
15.16.2.2. By Service
15.16.2.3. By Therapeutic Areas
15.16.2.4. By End-use
15.17. Saudi Arabia
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Device Type
15.17.2.2. By Service
15.17.2.3. By Therapeutic Areas
15.17.2.4. By End-use
15.18. UAE
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Device Type
15.18.2.2. By Service
15.18.2.3. By Therapeutic Areas
15.18.2.4. By End-use
15.19. Israel
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Device Type
15.19.2.2. By Service
15.19.2.3. By Therapeutic Areas
15.19.2.4. By End-use
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Device Type
16.3.3. By Service
16.3.4. By Therapeutic Areas
16.3.5. By End-use
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. SGS SA
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Toxikon, Inc.
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Eurofins Scientific
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. Pace Analytical Services LLC
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. Intertek Group plc
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Wuxi AppTec
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Envigo
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Charles River Laboratories
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. Medical Device Testing Services
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer